Literature DB >> 18988388

Clinical presentation and outcome of autosomal dominant polycystic kidney disease in Pakistan: a single center experience.

Malik Anas Rabbani1, Syed Sohail Ali, Ghulam Murtaza, Bushra Ahmad, Qamaruddin Maria, Bilal Karim Siddiqui, Syed Mansoor Ahmed Shah, Aasim Ahmad.   

Abstract

OBJECTIVE: To delineate clinical presentation and outcome of Autosomal Dominant Polycystic Kidney Disease (ADPKD) in terms of need for renal replacement therapy of kidney transplantation in Pakistani patients.
METHODS: Patients with ADPKD were identified using strict clinical criteria. Medical charts were evaluated retrospectively for initial presenting complaints, co-morbids, family history of ADPKD, any palpable mass on abdominal examination, cardiac examination for any abnormal finding and use of any anti-hypertensive drugs. Laboratory parameters were assessed. Chi square and Logistic regression analyses at 95% CI were used for statistical significance. A p value of less 0.05 was considered statistically significant.
RESULTS: A total of 56 patients fulfilled our criteria of ADPKD. There were 40 (71.4%) males and 16 (28.6%) females in our study. The mean age at the time of diagnosis of ADPKD was 47.0 +/- 14.5 years. Mean follow up period for all patients was 7.6 +/- 4.2 years. Most common form of presentation was hypertension in 38 (67.9%) patients. Kidneys were palpable in 33 (58.9%), liver in 16 (28.6%) and spleen in 6 patients (10.7%). Microscopic haematuria was observed in 38 (67.8%) patients while gross haematuria was present in 10 (17.9%) patients. The murmur of mitral valve prolapse was found in 10 patients on clinical examination which was later confirmed on transthoracic echocardiography (TEE). On MRI/MRA 2 (3.6%) patients each had berry aneurysm and AV malformations. Three patients (5.4%) received renal transplant and 19 (33.9%) patients were dialysis dependent at the end of study. A total 11 (20%) were lost to follow up. Two patients (3.5%) died during six years follow up. Male sex and uncontrolled hypertension were most important predictors of poor prognosis (p < 0.03 and < 0.048 respectively).
CONCLUSION: Pre-symptomatic patients with ADPKD should be monitored with blood pressure measurements and assessment of their renal function. The advantages of such monitoring include the ability to prevent or control infection and hypertension, to identify potential kidney donors from among the family, to offer advice on marriage and childbearing, and to provide prenatal diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 18988388

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  4 in total

1.  Identification of PKD1 and PKD2 gene variants in a cohort of 125 Asian Indian patients of ADPKD.

Authors:  Shewata Pandita; Vijaya Ramachandran; Prahlad Balakrishnan; Arndt Rolfs; Oliver Brandau; Sabrina Eichler; Anil Kumar Bhalla; Dinesh Khullar; Vindu Amitabh; Sivaramakrishnan Ramanarayanan; Vijay Kher; Jyotsna Verma; Sudha Kohli; Renu Saxena; Ishwar Chander Verma
Journal:  J Hum Genet       Date:  2019-02-28       Impact factor: 3.172

2.  RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.

Authors:  Hyunjin Ryu; Hayne C Park; Yun Kyu Oh; Irene Sangadi; Annette Wong; Changlin Mei; Tevfik Ecder; Angela Yee-Moon Wang; Tze-Wah Kao; Jenq-Wen Huang; Gopala K Rangan; Curie Ahn
Journal:  BMJ Open       Date:  2020-02-06       Impact factor: 2.692

3.  Stone Prevalence in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Vinusha Kalatharan; Gary Grewal; Danielle M Nash; Blayne Welk; Sisira Sarma; York Pei; Amit X Garg
Journal:  Can J Kidney Health Dis       Date:  2020-07-04

4.  Mitral Valve Prolapse and Its Motley Crew-Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition.

Authors:  Jordan E Morningstar; Annah Nieman; Christina Wang; Tyler Beck; Andrew Harvey; Russell A Norris
Journal:  J Am Heart Assoc       Date:  2021-06-22       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.